Shu et al. demonstrated that the overexpression of LINC00936 hindered ovarian cancer progression by competitively binding to miR-221-3p and modulating LAMA3 expression.7 Moreover, Xu et al. reported that LINC00628 could obstruct cell proliferation, invasion, migration, and apoptosis while reducing drug resistance in lung adenocarcinoma cells by downregulating the methylation of the LAMA3 promoter8. Here, ATP2B1-AS1 is linked to ovarian cancer.